Elan deal positions J&J ahead of Obamacare

With members of the baby-boom generation hitting retirement age in force in the next few years, drug companies are trying to line up the blockbuster medications that, they hope, will ease their suffering while also soothing investors’ nerves. Witness Johnson & Johnson agreeing to buy an equity stake in Irish drugmaker Elan.